Trinity Biotech plc (TRIB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.55M | -71.45K | -1.67M | -2.96M | 3.35M | -3.62M | -1.1M | -2.82M | 242K | -4.66M | -4.42M | -2.72M |
| Operating CF Margin % | -14.03% | -0.5% | -15.22% | -39.1% | 21.13% | -23.92% | -6.94% | -19.17% | 1.8% | -31.78% | -31.79% | -18.33% |
| Operating CF Growth % | -146.32% | 98.03% | -51.87% | -5.08% | 1284.71% | 22.3% | 75.1% | -3.72% | -89.36% | -789.94% | -562.13% | 38% |
| Net Income | -17.46M | -5.11M | -6.04M | -8.8M | -16.96M | -4.76M | -6.76M | -3.32M | -5.5M | -6.72M | -5.99M | -5.81M |
| Depreciation & Amortization | 728.46K | 657.06K | 665.28K | 638.48K | 424K | 598K | 153K | 691K | 462K | 229K | 484K | 602K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 140K | 250K | 114K | 812K | -1.01M | 738K | 975K | 1.36M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 585K | -35K | -131K | 0 | 0 | 222K | -267K | -11K |
| Other Non-Cash Items | 13.46M | 3.83M | 2.63M | 2.14M | 10.62M | 2.2M | 3.85M | 1.14M | 4M | 3.19M | 1.67M | 2.5M |
| Working Capital Changes | 1.73M | 550.29K | 1.08M | 3.07M | 8.54M | -1.88M | 1.67M | -2.14M | 2.29M | -2.33M | -1.29M | -1.36M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -800.99K | -1.46M | -2M | -1.98M | -2.74M | -3.1M | -3.17M | -13.96M | -891K | -886K | 27.86M | -1.33M |
| Capital Expenditures | -800.99K | -1.46M | -2M | -1.98M | -157K | -110K | -72K | -1.46M | -891K | -620K | -564K | -629K |
| CapEx % of Revenue | 7.24% | 10.26% | 18.19% | 26.18% | 0.99% | 0.73% | 0.45% | 9.95% | 6.64% | 4.22% | 4.06% | 4.24% |
| Acquisitions | 0 | 0 | 0 | 0 | -1K | -403K | 0 | -12.5M | 0 | -266K | 28.43M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -2.58M | -2.59M | -3.1M | 0 | 0 | -758K | 28.01M | -1.05M |
| Cash from Financing | 6.15M | 1.34M | 1.09M | 3.81M | 1.81M | 4.24M | 3.92M | 18.85M | -1.76M | -2.43M | -13.45M | 1.61M |
| Debt Issued (Net) | 7.01M | 2.14M | 1.89M | 4M | 1.34M | -678K | 5.9M | 21.12M | -555K | -571K | -10.49M | 4.25M |
| Equity Issued (Net) | -555 | -2.13K | 2.97K | 548.41K | 544K | 7.12M | 0 | -270K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -270K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -858.29K | -797.33K | -804.69K | -736.55K | -74K | -2.19M | -1.98M | -2M | -1.21M | -1.86M | -2.96M | -2.65M |
| Net Change in Cash | 3.8M | -205K | -2.52M | -1.1M | 2.33M | -2.48M | -459K | 2.08M | -2.57M | -7.97M | 10.07M | -2.42M |
| Free Cash Flow | -1.54M | -77.11K | -1.71M | -3.02M | 615K | -6.32M | -4.27M | -6.29M | -1.86M | -5.28M | -4.98M | -3.35M |
| FCF Margin % | -13.93% | -0.54% | -15.56% | -39.84% | 3.88% | -41.73% | -26.93% | -42.75% | -13.83% | -36% | -35.85% | -22.57% |
| FCF Growth % | -350.55% | 98.78% | 59.97% | 51.98% | 133.12% | -19.66% | 14.35% | -87.81% | -263.32% | -715.43% | -6370.13% | 51.26% |
| FCF per Share | -0.08 | -0.00 | -0.09 | -0.16 | 0.04 | -0.61 | -0.45 | -0.71 | -0.24 | -0.69 | -0.65 | -0.44 |
| FCF Conversion (FCF/Net Income) | 0.09x | 0.01x | 0.28x | 0.34x | -0.20x | 0.76x | 0.16x | 0.85x | -0.04x | 0.69x | 0.74x | 0.43x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |